C-Peptide

Recombinant human glutamic acid decarboxylase formulated with aluminum hydroxide may preserve C-peptide and improve HbA1c for people with type 1 diabetes carrying a specific genotype, according to findings from a meta-analysis.

Adults with type 2 diabetes and higher C-peptide levels are more likely to develop simple nonalcoholic fatty liver disease and nonalcoholic steatohepatitis compared with those with lower levels, according to findings published in DiabetesMetabolism Research and Reviews. In contrast, those with higher C-peptide levels are less likely to have advanced fibrosis.

A C-peptide level of more than 20 pmol/L may indicate a lower risk for hypoglycemia among adults with type 1 diabetes, suggesting that these individuals may safely pursue tighter glycemic targets, according to findings published in Diabetic Medicine.